Band 55
Progress in Drug Research
Aus der Reihe
Progress in Drug Research
-
- Hardcover
- Taschenbuch ausgewählt
- eBook
-
Sprache:Englisch
-
Auflage:Softcover reprint of the original 1st ed. 2000
- Softcover reprint of the original 1st ed. 2002 Fr. 242.00
- Softcover reprint of the original 1st ed. 2002 Fr. 242.00
- Softcover reprint of the original 1st ed. 2001 Fr. 138.00
- Softcover reprint of the original 1st ed. 2000 Fr. 72.90
- Softcover reprint of the original 1st ed. 2000 Fr. 72.90 ausgewählt
- 1. Auflage Fr. 137.00
- Softcover reprint of the original 1st ed. 2003 Fr. 242.00
- Softcover reprint of the original 1st ed. 1999 Fr. 72.90
- Softcover reprint of the original 1st ed. 1998 Fr. 72.90
- Softcover reprint of the original 1st ed. 1998 Fr. 137.00
- Softcover reprint of the original 1st ed. 1997 Fr. 72.90
- Softcover reprint of the original 1st ed. 1985 Fr. 72.90
- Softcover reprint of the original 1st ed. 1989 Fr. 72.90
Fr. 72.90
inkl. gesetzl. MwSt.,
Beschreibung
Produktdetails
Einband
Taschenbuch
Erscheinungsdatum
30.10.2012
Verlag
Springer BaselSeitenzahl
336
Maße (L/B/H)
25.4/17.8/1.9 cm
Gewicht
662 g
Auflage
Softcover reprint of the original 1st ed. 2000
Sprache
Englisch
ISBN
978-3-0348-9544-6
Hepatitis C virus (HCV) was first identified in 1989 as the etiologic agent of non-A, non-B hepatitis [1] and is currently recognized as the leading cause of chronic liver disease worldwide. In contrast to hepatitis B virus infection, in which only about 5% of adult infections become chronic, more than 80% of HCV-infected patients develop chronic hepatitis. Moreover, 20-50% of those persistently infected with HCV will develop liver cirrhosis and hepatocellu lar carcinoma (HCC) [2]. It is estimated that there are 10,000 deaths in the USA per year due to chronic liver failure or HCC [3]. In addition, HCV dis 25-50% of all liver transplants in US centers, and the ease is responsible for recurrence of HCV infection following liver transplantation is universal [4]. Typically, HCV disease emerges after a 10-20 year period during which symp toms, if they exist at all, are mild and non-specific. Although the prevalence varies greatly among different countries, it has been estimated that up to 170 million people (3% of the world's population), are infected with HCV [5]. A recent study in the USA found that 65% of all HCV-infected persons are 30 to 49 years old [6].
Kundinnen und Kunden meinen
Verfassen Sie die erste Bewertung zu diesem Artikel
Helfen Sie anderen Kund*innen durch Ihre Meinung